Invitation to Roche’s Virtual Neurology Investor Event Montag, 12. Februar 2024 - 10:17

Investor Update

Invitation to Roche's Virtual Neurology Investor Event

We are pleased to invite investors and analysts to participate in our virtual event on Monday,

11 March 2024, highlighting key data presented at 2024 Muscular Dystrophy Association (MDA) and Alzheimer's & Parkinson's Diseases (AD/PD) conferences.

15:00 – 16:30 CET / 14:00 – 15:30 GMT

10:00 – 11:30 AM EDT / 07:00 – 08:30 AM PDT

The webinar will start with presentations, followed by a Q&A session (live access to the speakers). The slides will be available for download at 14:00 CET on the day of the event. >click here

Access to virtual event (pre-registration required)

Please pre-register for our webinar here.*

Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com.

A replay of the webinar will be available via > ir.roche.com

*privacy notice

Best regards,

Bruno Eschli
Head of Investor Relations

Loren Kalm

Head of Investor Relations, North America

Roche Investor Relations
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com

Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com